Photosynthetic Production of Ethanol Using Genetically Engineered Cyanobacteria

2020 ◽  
pp. 99-113
Author(s):  
F. P. De Andrade ◽  
M. L. F. De Sá Filho ◽  
R. R. L. Araújo ◽  
T. R. M. Ribeiro ◽  
A. E. Silva ◽  
...  
Keyword(s):  
Genetically Engineered ◽  
Photosynthetic Production

scholarly journals Enhancing photosynthetic production of ethylene in genetically engineered Synechocystis sp. PCC 6803

2015 ◽  
Vol 17 (1) ◽  
pp. 421-434 ◽  
Author(s):  
Tao Zhu ◽  
Xiaoman Xie ◽  
Zhimin Li ◽  
Xiaoming Tan ◽  
Xuefeng Lu
Keyword(s):  
Ethylene Production ◽  
Genetically Engineered ◽  
Genetic Modifications ◽  
Photosynthetic Production ◽  
Synechocystis Sp ◽  
Pcc 6803

The enhanced ethylene production (9.7 mL L−1h−1) was achieved by genetic modifications and improved cultivation ofSynechocystissp. PCC 6803.

scholarly journals Correction: Photosynthetic production of ethanol from carbon dioxide in genetically engineered cyanobacteria

2016 ◽  
Vol 9 (3) ◽  
pp. 1113-1113 ◽  
Author(s):  
Zhengxu Gao ◽  
Hui Zhao ◽  
Zhimin Li ◽  
Xiaoming Tan ◽  
Xuefeng Lu
Keyword(s):  
Carbon Dioxide ◽  
Genetically Engineered ◽  
Photosynthetic Production ◽  
Energy Environ

Correction for ‘Photosynthetic production of ethanol from carbon dioxide in genetically engineered cyanobacteria’ by Zhengxu Gao et al., Energy Environ. Sci., 2012, 5, 9857–9865.

Photosynthetic production of ethanol from carbon dioxide in genetically engineered cyanobacteria

2012 ◽  
Vol 5 (12) ◽  
pp. 9857-9865 ◽  
Author(s):  
Zhengxu Gao ◽  
Hui Zhao ◽  
Zhimin Li ◽  
Xiaoming Tan ◽  
Xuefeng Lu
Keyword(s):  
Carbon Dioxide ◽  
Genetically Engineered ◽  
Photosynthetic Production

Reproductive health issues in patients with psoriasis (literature review)

2019 ◽  
Vol 1 (7) ◽  
pp. 5-8
Author(s):  
L. S. Kruglova ◽  
A. A. Osina ◽  
A. A. Khotko
Keyword(s):  
Drug Therapy ◽  
Reproductive Health ◽  
Literature Review ◽  
Pregnancy Outcomes ◽  
Adverse Pregnancy Outcome ◽  
Certolizumab Pegol ◽  
Genetically Engineered ◽  
Health Issues ◽  
Degree Of Confidence ◽  
Adverse Pregnancy

Among patients with psoriasis, approximately 50% are women and almost 75 % of them are under the age of 40 years. Thus, most women with psoriasis have childbearing potential. When pregnancy occurs in 22 % of patients, the activity of psoriasis persists, characteristic of the course before pregnancy, in 23 % of women, the course of the disease worsens. The article provides up-to-date data on the management of pregnant patients with psoriasis. To improve pregnancy outcomes in patients with psoriasis, it is important to prevent exacerbation of the disease. The choice of drug therapy in this case is based on an assessment of the ratio of the risk of undesirable effects of the drugs on the developing fetus and the risk of the development of exacerbation of psoriasis, which can cause an adverse pregnancy outcome. Despite the fact that the available clinical experience of using genetically engineered drugs is still limited, with a certain degree of confidence we can say that there is no increase in the risk of adverse pregnancy outcomes associated with therapy with certolizumab pegol.

Quantum Dot Bioconjugates as Energy Donors in Fluorescence Resonance Energy Transfer Assays

2003 ◽  
Vol 773 ◽  
Author(s):  
Aaron R. Clapp ◽  
Igor L. Medintz ◽  
J. Matthew Mauro ◽  
Hedi Mattoussi
Keyword(s):  
Energy Transfer ◽  
Quantum Dot ◽  
Organic Dyes ◽  
Resonance Energy Transfer ◽  
Resonance Energy ◽  
Genetically Engineered ◽  
Molar Ratio ◽  
Binding Assays ◽  
Specific Sequence ◽  
Donor Acceptor

AbstractLuminescent CdSe-ZnS core-shell quantum dot (QD) bioconjugates were used as energy donors in fluorescent resonance energy transfer (FRET) binding assays. The QDs were coated with saturating amounts of genetically engineered maltose binding protein (MBP) using a noncovalent immobilization process, and Cy3 organic dyes covalently attached at a specific sequence to MBP were used as energy acceptor molecules. Energy transfer efficiency was measured as a function of the MBP-Cy3/QD molar ratio for two different donor fluorescence emissions (different QD core sizes). Apparent donor-acceptor distances were determined from these FRET studies, and the measured distances are consistent with QD-protein conjugate dimensions previously determined from structural studies.

Sign in / Sign up

Export Citation Format

Share Document